The CaMKKβ-AMPK-ULK1 signaling pathway is regulated by fenofibrate, leading to the activation of lysosomal Ca2+ levels, induction of TFEB activation, promotion of fat phagocytosis, and ultimately improvement in fat accumulation in NAFLD. The gene discussed is CAMKK2; the disease is metabolic dysfunction-associated steatotic liver disease.